Your browser doesn't support javascript.
loading
Tuberculosis preventive treatment in newborns.
TannousTahan, Tony; Rossoni, Andrea Maciel de Oliveira; Lugarini, Giuliana; de Oliveira, Simoni Pimenta; Taques, Juliana; Santos, Mauricio Bedim Dos; Gabardo, Betina Mendez Alcântara; Hirose, Tatiane Emi; Rodrigues, Cristina de Oliveira.
Afiliación
  • TannousTahan T; Universidade Federal do Paraná, Curitiba, PR, Brazil. Electronic address: tony.tahan@hotmail.com.
  • Rossoni AMO; Universidade Federal do Paraná, Curitiba, PR, Brazil; Rede Brasileira de Pesquisa em Tuberculose - RedeTB, Brazil.
  • Lugarini G; Universidade Tecnológica Federal do Paraná, Curitiba, PR, Brazil.
  • de Oliveira SP; Secretaria de Saúde do Estado do Paraná, Curitiba, PR, Brazil.
  • Taques J; Secretaria de Saúde do Estado do Paraná, Curitiba, PR, Brazil.
  • Santos MBD; Universidade Federal do Paraná, Curitiba, PR, Brazil.
  • Gabardo BMA; Universidade Federal do Paraná, Curitiba, PR, Brazil.
  • Hirose TE; Universidade Federal do Paraná, Curitiba, PR, Brazil.
  • Rodrigues CO; Universidade Federal do Paraná, Curitiba, PR, Brazil.
J Pediatr (Rio J) ; 2024 Aug 08.
Article en En | MEDLINE | ID: mdl-39127460
ABSTRACT

OBJECTIVE:

To describe the reported cases of newborns subjected to tuberculosis preventive treatment (TPT) in the state of Paraná, Brazil, and to evaluate the safety and effectiveness in preventing the progression of TB disease in this population.

METHOD:

Observational, descriptive case series, with secondary data. The characteristics of the participants were analyzed from the information systems of preventive treatment of TB (of Paraná), between 2009 and 2016. To evaluate which children had developed tuberculosis later or died, we used the data from the information systems of TB (in Brazil), and mortality (in Paraná), covering the years 2009 to 2018.

RESULTS:

A total of 24 children underwent TPT with the age at treatment onset ranging from 0 to 87 days (median 23 days). In 95.8 %, the exposure occurred at home, and in 33.3 % of cases, the mother was the source of the infection. A total of 20.8 % of the children tested positive for tuberculosis test at 3 months of age, 83.3 % completed treatment, and 2 experienced adverse events (gastrointestinal issues). No children developed TB or died during the minimum of a 2-year evaluation period through the official databases.

CONCLUSIONS:

In this case series, the adherence to the plan was high, with few adverse events and 100 % protection against infection.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: J Pediatr (Rio J) Año: 2024 Tipo del documento: Article Pais de publicación: Brasil

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: J Pediatr (Rio J) Año: 2024 Tipo del documento: Article Pais de publicación: Brasil